中国P站

The advancement of quantitative protein profiling methods, particularly those employing liquid chromatography-mass spectrometry (LC-MS), has significantly enhanced the ability to analyze complex biological samples. One notable application involves the robust profiling of exosomal proteins, which are crucial intercellular communication vesicles. This approach holds considerable promise for accurate biomarker discovery in various diseases, facilitating deeper insights into pathological processes [1].

Understanding cellular heterogeneity is paramount in modern biological and medical research, and advanced multiplexed protein profiling techniques offer powerful tools for this endeavor. These methodologies enable the simultaneous analysis of numerous proteins within single cells, thereby providing unprecedented insights into individual cellular responses. Such detailed analysis is critical for elucidating complex disease mechanisms at a fundamental level [2].

Recent technological advancements have propelled spatial protein profiling to the forefront of tissue analysis, revolutionizing how researchers investigate biological systems. These innovative methods provide invaluable contextual information, allowing for a precise understanding of protein function and intricate interactions within their native, complex biological environments. This spatial context is indispensable for deciphering cellular organization and disease progression [3].

The search for reliable disease biomarkers is a continuous effort, with mass spectrometry-based protein profiling of human plasma emerging as a key strategy. This methodology offers a powerful platform to identify unique protein signatures indicative of various diseases. Despite inherent challenges, it holds significant potential for enhancing early diagnosis and improving prognostic assessments, paving the way for more effective clinical interventions [4].

Single-cell proteomics represents a rapidly evolving field that is transforming the understanding of cellular biology by enabling protein profiling at the individual cell level. Current advances in these techniques are instrumental in dissecting cellular heterogeneity with unparalleled resolution. Such detailed insights into individual cellular functional states are vital for comprehending both health and disease processes comprehensively [5].

Extracellular vesicles (EVs) have gained considerable attention for their roles in intercellular communication and their potential as diagnostic tools. Comprehensive proteomic profiling of these vesicles is particularly promising for cancer diagnosis. This non-invasive approach offers novel avenues for the early detection and continuous monitoring of various types of cancers, representing a significant leap in clinical diagnostics [6].

Chemical proteomics has emerged as a powerful discipline for comprehensive protein profiling and the identification of specific therapeutic targets. Advances in these techniques facilitate the precise mapping of protein-ligand interactions and the elucidation of complex cellular pathways. This capability is profoundly contributing to the drug discovery process, enabling the development of more targeted and effective pharmaceutical agents [7].

High-throughput protein profiling methodologies, suchs as proximity extension assays, are increasingly vital for accelerating biomarker discovery in clinical settings. These assays enable the sensitive and simultaneous measurement of a large number of proteins from biological samples. Their utility lies in their capacity to provide broad proteomic insights efficiently, which is critical for identifying potential diagnostic and prognostic indicators across diverse clinical contexts [8].

Investigating neurodegenerative diseases necessitates a deep understanding of molecular alterations within affected tissues. Proteomic profiling of human brain tissue from patients afflicted with Alzheimer's disease has been instrumental in this regard. Such studies identify specific protein changes that may serve as crucial biomarkers or novel therapeutic targets, thereby contributing significantly to unraveling the disease’s complex progression [9].

Liquid biopsies, offering a non-invasive alternative to traditional tissue biopsies, have revolutionized cancer detection and monitoring. Protein profiling of biofluids collected through liquid biopsies is a particularly exciting area. This approach holds immense potential for the early and non-invasive diagnosis of cancer, as well as for effectively monitoring treatment efficacy and disease recurrence [10].

Description

A detailed study delineated a robust liquid chromatography-mass spectrometry method specifically tailored for the quantitative protein profiling of exosomes. This methodical approach is designed to accurately analyze proteins within these critical intercellular communication vesicles, emphasizing its significant potential. The described technique aims to facilitate precise biomarker discovery crucial for diagnosing and understanding various disease states [1]. A review paper systematically examined advanced multiplexed protein profiling techniques applied to single cells, highlighting their central role in deciphering cellular heterogeneity. The discussion covered various methodologies that permit deeper investigations into how individual cells respond to stimuli and contribute to disease mechanisms. This comprehensive overview underscores the necessity of single-cell analysis for detailed biological insights [2]. Recent progress in spatial protein profiling technologies was extensively explored, focusing on their transformative impact on tissue analysis. The article elaborated on how these cutting-edge methods provide an essential context for interpreting protein function and their intricate interactions within native, complex biological environments. This technological leap enables researchers to visualize molecular processes with unprecedented spatial resolution [3]. Research detailed mass spectrometry-based protein profiling applied to human plasma with the goal of identifying disease biomarkers. The work meticulously outlined the methodologies employed and the challenges encountered in discovering reliable protein signatures. This initiative is particularly geared towards improving early diagnosis and enhancing the accuracy of prognostic assessments in clinical applications [4]. A comprehensive review summarized the latest developments in single-cell proteomics, specifically addressing techniques for protein profiling at the individual cell level. The authors emphasized how these innovative approaches significantly advance the understanding of cellular heterogeneity and the functional states of cells, both in healthy conditions and during disease progression, offering a granular view of cellular biology [5]. An article focused on the comprehensive proteomic profiling of extracellular vesicles, exploring their application in cancer diagnosis. The research underscored the considerable potential of these vesicles as non-invasive biomarkers. This methodology offers new and promising avenues for the early detection and subsequent monitoring of various types of cancers, representing a crucial step in oncological diagnostics [6]. Recent advancements within chemical proteomics were highlighted, specifically regarding comprehensive protein profiling and target identification strategies. The review elucidated how these specialized techniques facilitate the precise mapping of protein-ligand interactions and unravel intricate cellular pathways. Such capabilities are profoundly accelerating the process of drug discovery and development [7]. The utility of high-throughput protein profiling, achieved through proximity extension assays, was thoroughly examined. This paper demonstrated the effectiveness of these assays in simultaneously measuring a large array of proteins with exceptional sensitivity. This capability is deemed vital for accelerating biomarker discovery across a wide range of clinical contexts, providing robust and efficient screening tools [8]. Research delved into the proteomic profiling of human brain tissue obtained from patients suffering from Alzheimer's disease. The study successfully identified specific protein alterations associated with the disease progression. These identified changes hold promise as potential biomarkers for diagnosis or as novel therapeutic targets, contributing significantly to the understanding and treatment of this complex neurodegenerative disorder [9]. A review article addressed protein profiling of biofluids within the context of liquid biopsies for cancer detection. It elaborated on the significant potential of analyzing circulating proteins in accessible samples like blood or urine. This non-invasive approach is highlighted for its capacity to enable early cancer diagnosis and to effectively monitor the efficacy of ongoing treatments [10].

Conclusion

The field of protein profiling has undergone significant advancements, enabling researchers to gain unprecedented insights into biological systems and disease mechanisms. Diverse methodologies are employed, ranging from robust liquid chromatography-mass spectrometry for quantitative analysis of exosomes to advanced multiplexed and single-cell proteomics techniques for dissecting cellular heterogeneity. Spatial protein profiling provides crucial contextual information for tissue analysis, while mass spectrometry-based approaches are refined for disease biomarker discovery in human plasma and biofluids. Extracellular vesicles are increasingly recognized for their potential as non-invasive biomarkers, particularly in cancer diagnosis, leading to comprehensive proteomic profiling efforts. Chemical proteomics contributes to drug discovery by identifying targets and mapping protein-ligand interactions. High-throughput methods, such as proximity extension assays, enhance biomarker identification across clinical contexts. Furthermore, these techniques are applied to specific disease states, such as proteomic profiling of brain tissue for Alzheimer's disease, to identify therapeutic targets and understand disease progression. Collectively, these advancements highlight a growing capacity for precise, sensitive, and high-throughput protein analysis, essential for early diagnosis, prognosis, and therapeutic development across various medical disciplines.

References

1. Zhiyao L, Xinyu W, Yulin L. (2021) .J Proteome Res 20:3905-3913.

   , ,

2. Zeeshan A, Michael OTS, Jian-Yu Z. (2020) .Curr Opin Biotechnol 65:109-115.

   , ,

3. Yibing S, Jichao W, Yanyue W. (2023) .Clin Transl Med 13:e1287.

   , ,

4. Minghui Y, Zhen L, Li-Min M. (2022) .Anal Chem 94:5838-5846.

   , ,

5. Yue H, Weidong L, Weilin L. (2024) .TrAC Trends Anal Chem 170:117260.

   , ,

6. Yan S, Bo Z, Xinrui W. (2020) .Cancer Lett 493:17-26.

   , ,

7. Yu W, Jian-Long L, Bing Y. (2023) .J Pharm Anal 13:549-563.

   , ,

8. Katja H, Maria L, Jochen S. (2019) .Clin Chem 65:477-483.

   , ,

9. Sara VMO, Christian DS, Tormod R. (2020) .J Alzheimers Dis 77:1721-1736.

   , Google Scholar,

10. Xiao-Fan Z, Wen-Qiang J, Lin-Hua Z. (2021) .Front Oncol 11:785028.

    , ,